<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39421860</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Long-term COVID-19 sequelae by Theta and SARS-CoV-2 variants in a Philippine cohort.</ArticleTitle><Pagination><StartPage>1455729</StartPage><MedlinePgn>1455729</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1455729</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1455729</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Millions have been infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) since its emergence in 2019, but most patients make a full recovery. The long-term consequences of the infection are anticipated to unravel in the succeeding years with reports of patients experiencing chronic, debilitating sequelae post-infection commonly referred to as Long COVID. Various Variants of Concern (VoCs) have emerged as the SARS-CoV-2 virus evolved displaying increased infectivity and immune evasiveness. We investigate whether the infecting VoCs affect the sequelae of Long COVID in a Philippine cohort.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">SARS-CoV-2 cases confirmed using RT-PCR followed by Next Generation Sequencing were identified from selected regions of the Philippines and recruited through a retrospective-prospective cohort design. Participants were divided based on the initial infecting VoC or Variant of Interest (VoI) and were subsequently interviewed regarding the presence, intensity, and frequency of key Long COVID symptoms, and followed up on two more separate sessions at least three (3) months apart for a total of three (3) data collection points (S1, S2, S3) to document changes in symptoms throughout the year-long study period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Long COVID symptoms were reported in 88, 82, and 68% of participants in S1, S2, and S3, respectively, showing declining incidence with elapsed time since the first reported infection. General symptoms including headache, fatigue, and post-exertional malaise were the most frequently reported symptoms, while neuropsychiatric symptoms were the second most frequently reported symptoms. In all three (3) sessions, intermittent brain fog, fatigue, and headache were the most frequently reported symptoms in all SARS-CoV-2 variant cohorts. Factors such as age, sex, comorbidities, and disease severity influenced symptom frequency, providing insight into the risk factors that contribute to the prevalence of this disease.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">A large proportion (&gt;68%) of cases in this Philippine cohort previously infected with different SARS-CoV-2 variants presented with long-term complications of COVID-19 characterized by a highly heterogeneous set of debilitating symptoms. The study highlights the need for long-term monitoring of Long COVID and its impact on human health and the need for our health systems to adopt policy response strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Saloma, Ayes, Taracatac and Asa.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Saloma</LastName><ForeName>Cynthia P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Philippine Genome Center, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Molecular Biology and Biotechnology, College of Science, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ayes</LastName><ForeName>Marc Edsel C</ForeName><Initials>MEC</Initials><AffiliationInfo><Affiliation>Philippine Genome Center, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taracatac</LastName><ForeName>Paolo S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Philippine Genome Center, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asa</LastName><ForeName>Meryl Rose Q</ForeName><Initials>MRQ</Initials><AffiliationInfo><Affiliation>Philippine Genome Center, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">genomic biosurveillance</Keyword><Keyword MajorTopicYN="N">variants</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39421860</ArticleId><ArticleId IdType="pmc">PMC11483863</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1455729</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Coronavirus (COVID-19) dashboard. WHO COVID-19 dashboard (2024). Available at:
https://data.who.int/dashboards/covid19/cases (accessed January 30, 2024)</Citation></Reference><Reference><Citation>Aleem A, Akbar Samad AB, Vaqar S. Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19) In: StatPearls. Treasure Island (FL): StatPearls Publishing; (2024)</Citation><ArticleIdList><ArticleId IdType="pubmed">34033342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tablizo FA, Saloma CP, Castro MJR, Kim KM, Yangzon MSL, Lapid CM, et al. . Detection and genome sequencing of SARS-CoV-2 variants belonging to the B.1.1.7 lineage in the Philippines. Microbiol Resour Announc. (2021) 10:e00219&#x2013;21. doi: 10.1128/MRA.00219-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.00219-21</ArticleId><ArticleId IdType="pmc">PMC8103862</ArticleId><ArticleId IdType="pubmed">33958417</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y-T, Polotan FGM, Sotelo GIS, Alpino APA, Dolor AYM, MaAA T, et al. . Lineage BA.2 dominated the omicron SARS-CoV-2 epidemic wave in the Philippines. Virus. Evolution. (2022) 8:veac078. doi: 10.1093/ve/veac078, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac078</ArticleId><ArticleId IdType="pmc">PMC9452094</ArticleId><ArticleId IdType="pubmed">36090771</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr Clin Res Rev. (2021) 15:869&#x2013;75. doi: 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. (2022) 18:4768&#x2013;80. doi: 10.7150/ijbs.75056, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: how to define it and how to manage it. BMJ. (2020) 370:m3489. doi: 10.1136/bmj.m3489, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. (2020) 20:363&#x2013;74. doi: 10.1038/s41577-020-0311-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. (2022) 399:2263&#x2013;4. doi: 10.1016/S0140-6736(22)00941-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinicci M, Graziani L, Tilli M, Nkurunziza J, Vellere I, Borchi B, et al. . Infection with SARS-CoV-2 variants is associated with different Long COVID phenotypes. Viruses. (2022) 14:2367. doi: 10.3390/v14112367, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112367</ArticleId><ArticleId IdType="pmc">PMC9698829</ArticleId><ArticleId IdType="pubmed">36366465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: current definition. Infection. (2022) 50:285&#x2013;6. doi: 10.1007/s15010-021-01696-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Haw NJL, Ca&#xf1;al EMR, Zuasula J, Loreche MJ, Bernadas J. Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020&#x2013;16 February 2021. Western Pac Surveill Response J. (2022) 13:1&#x2013;3. doi: 10.5365/wpsar.2022.13.1.883, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5365/wpsar.2022.13.1.883</ArticleId><ArticleId IdType="pmc">PMC8935296</ArticleId><ArticleId IdType="pubmed">35355903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bascos NA, Mirano-Bascos D, Abesamis KI, Bagoyo CA, Mallapre OT, Saloma C. Structural analysis of spike protein mutations in the SARS-CoV-2 Theta (P.3) variant. Philipp J Sci. (2021) 150:1207&#x2013;24. doi: 10.56899/150.05.31</Citation><ArticleIdList><ArticleId IdType="doi">10.56899/150.05.31</ArticleId></ArticleIdList></Reference><Reference><Citation>Tablizo FA, Kim KM, Lapid CM, Castro MJR, Yangzon MSL, et al. . Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas region of the Philippines [preprint]. (2021). Available at:
https://www.medrxiv.org/content/10.1101/2021.03.03.21252812v2 (accessed August 12, 2024)</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252812v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. (2018) 34:3094&#x2013;100. doi: 10.1093/bioinformatics/bty191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty191</ArticleId><ArticleId IdType="pmc">PMC6137996</ArticleId><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. . 1000 genome project data processing subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics. (2009) 25:2078&#x2013;9. doi: 10.1093/bioinformatics/btp352, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubaugh ND, Gangavarapu K, Quick J, Matteson NL, De Jesus JG, Main BJ, et al. . An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. (2019) 20:8. doi: 10.1186/s13059-018-1618-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1618-7</ArticleId><ArticleId IdType="pmc">PMC6325816</ArticleId><ArticleId IdType="pubmed">30621750</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Holmes EC, O&#x2019;Toole &#xc1;, Hill V, McCrone JT, Ruis C, et al. . A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. (2020) 5:1403&#x2013;7. doi: 10.1038/s41564-020-0770-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0770-5</ArticleId><ArticleId IdType="pmc">PMC7610519</ArticleId><ArticleId IdType="pubmed">32669681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, et al. . Versatile and open software for comparing large genomes. Genome Biol. (2004) 5:R12. doi: 10.1186/gb-2004-5-2-r12, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2004-5-2-r12</ArticleId><ArticleId IdType="pmc">PMC395750</ArticleId><ArticleId IdType="pubmed">14759262</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto TD, Dillon GP, Degrave WS, Berriman M. RATT: rapid annotation transfer tool. Nucleic Acids Res. (2011) 39:e57. doi: 10.1093/nar/gkq1268, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1268</ArticleId><ArticleId IdType="pmc">PMC3089447</ArticleId><ArticleId IdType="pubmed">21306991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. . Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. (2018) 34:4121&#x2013;3. doi: 10.1093/bioinformatics/bty407, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, et al. . Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. (2021) 21:70&#x2013;84. doi: 10.1016/S1473-3099(20)30586-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30586-7</ArticleId><ArticleId IdType="pubmed">32805200</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistica. Philippines: COVID-19 vaccine rollout 2023. Statista (2023). Available at:
https://www.statista.com/statistics/1236727/philippines-coronavirus-covid19-vaccine-rollout/ (accessed March 1, 2024)</Citation></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. (2021) 372:n693. doi: 10.1136/bmj.n693, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature. (2021) 590:29&#x2013;31. doi: 10.1038/d41586-021-00149-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00149-1</ArticleId><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Post COVID-19 condition (Long COVID). (2022). Available at:
https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (accessed February 27, 2024)</Citation></Reference><Reference><Citation>Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, et al. . Long COVID science, research and policy. Nat Med. (2024) 30:2148&#x2013;2164. doi: 10.1038/s41591-024-03173-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-03173-6</ArticleId><ArticleId IdType="pubmed">39122965</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or Long COVID: a Meta-analysis and systematic review. J Infect Dis. (2022) 226:1593&#x2013;607. doi: 10.1093/infdis/jiac136, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. (2021) 11:16144. doi: 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie H, Roser M, Rosado P. Philippines: coronavirus pandemic country profile. Our world in data (2020). Available at:
https://ourworldindata.org/coronavirus/country/philippines (accessed August 10, 2024)</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee N, Sarkar P, Sarkar T. Beyond the acute illness: exploring long COVID and its impact on multiple organ systems. Physiol Int. (2023) 110:291&#x2013;310. doi: 10.1556/2060.2023.00256, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2023.00256</ArticleId><ArticleId IdType="pubmed">37943302</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai C-L. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. (2021) 9:966. doi: 10.3390/biomedicines9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Brain fog as a Long-term sequela of COVID-19. SN Compr Clin Med. (2022) 5:9. doi: 10.1007/s42399-022-01352-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01352-5</ArticleId><ArticleId IdType="pmc">PMC9685075</ArticleId><ArticleId IdType="pubmed">36466122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatys-Bogacka Z, Mazurkiewicz I, Slowik J, Bociaga-Jasik M, Dzieza-Grudnik A, Slowik A, et al. . Brain fog and quality of life at work in non-hospitalized patients after COVID-19. Int J Environ Res Public Health. (2022) 19:12816. doi: 10.3390/ijerph191912816, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912816</ArticleId><ArticleId IdType="pmc">PMC9564568</ArticleId><ArticleId IdType="pubmed">36232113</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho S-J, Harriott AM, Garc&#xed;a-Azor&#xed;n D, Labastida-Ramirez A, et al. . Long COVID headache. J Headache Pain. (2022) 23:93. doi: 10.1186/s10194-022-01450-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Giamberardino MA, Martelletti P. Long COVID and especially headache syndromes. Curr Opin Neurol. (2023) 36:168&#x2013;74. doi: 10.1097/WCO.0000000000001153, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001153</ArticleId><ArticleId IdType="pubmed">37078648</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra N, Grill MF, Singh RBH. Post-COVID headache: a literature review. Curr Pain Headache Rep. (2022) 26:835&#x2013;42. doi: 10.1007/s11916-022-01086-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01086-y</ArticleId><ArticleId IdType="pmc">PMC9533267</ArticleId><ArticleId IdType="pubmed">36197571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierle DM, Aakre CA, Grach SL, Salonen BR, Croghan IT, Hurt RT, et al. . Central sensitization phenotypes in post acute sequelae of SARS-CoV-2 infection (PASC): defining the post COVID syndrome. J Prim Care Community Health. (2021) 12:21501327211030826. doi: 10.1177/21501327211030826, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211030826</ArticleId><ArticleId IdType="pmc">PMC8267019</ArticleId><ArticleId IdType="pubmed">34231404</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. (2021) 92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. . Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. (2022) 14:2629. doi: 10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. . Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. (2020) 6:00542&#x2013;2020. doi: 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A, et al. . Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: a prospective cohort study. J Infect. (2022) 84:566&#x2013;72. doi: 10.1016/j.jinf.2022.02.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, Seferovic J, Ivkovic V, Gallina S, et al. . Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: gender makes a difference. Trends Cardiovasc Med. (2022) 32:12&#x2013;7. doi: 10.1016/j.tcm.2021.09.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla AS, et al. . The conundrum of &#x2018;Long-COVID-19&#x2032;: a narrative review. Int J Gen Med. (2021) 14:2491&#x2013;506. doi: 10.2147/IJGM.S316708</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. (2022) 53:624. doi: 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, Pouwels KB, Glickman M, Nafilyan V, et al. . Risk of Long COVID in People infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis. (2022) 9:ofac464. doi: 10.1093/ofid/ofac464</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Metaxaki M, Wills MR, Sithole N. Reduced incidence of Long coronavirus disease referrals to the Cambridge university teaching hospital Long coronavirus disease clinic. Clin Infect Dis. (2023) 76:738&#x2013;40. doi: 10.1093/cid/ciac630, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac630</ArticleId><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of Long COVID: an international survey of people with lived experience of Long COVID. Vaccine. (2022) 10:652. doi: 10.3390/vaccines10050652, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. (2023) 2:e000385. doi: 10.1136/bmjmed-2022-000385, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W-T, Huang W-H, Liao T-L, Hsiao T-H, Chuang H-N, Liu P-Y. SARS-CoV-2 E484K mutation narrative review: epidemiology, immune escape, clinical implications, and future considerations. Infect Drug Resist. (2022) 15:373&#x2013;85. doi: 10.2147/IDR.S344099</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S344099</ArticleId><ArticleId IdType="pmc">PMC8820839</ArticleId><ArticleId IdType="pubmed">35140483</ArticleId></ArticleIdList></Reference><Reference><Citation>Boufidou F, Medi&#x107; S, Lampropoulou V, Siafakas N, Tsakris A, Anastassopoulou C. SARS-CoV-2 reinfections and Long COVID in the post-omicron phase of the pandemic. Int J Mol Sci. (2023) 24:12962. doi: 10.3390/ijms241612962, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="pubmed">37629143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A, Sheikh AAE, Khan AM, Khalid SN, Khan J, Nasrullah A, et al. . COVID-19 vaccine and Long COVID: a scoping review. Life. (2022) 12:1066. doi: 10.3390/life12071066, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Aceituno A, Garc&#xed;a-Hern&#xe1;ndez A, Larumbe-Zabala E. COVID-19 long-term sequelae: omicron versus alpha and Delta variants. Infect Dis Now. (2023) 53:104688. doi: 10.1016/j.idnow.2023.104688, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104688</ArticleId><ArticleId IdType="pmc">PMC9970656</ArticleId><ArticleId IdType="pubmed">36858287</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas LS, Molteni E, Deng J, Sudre CH, Murray B, Kerfoot E, et al. . Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet Digit Health. (2023) 5:e421&#x2013;34. doi: 10.1016/S2589-7500(23)00056-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(23)00056-0</ArticleId><ArticleId IdType="pmc">PMC10187990</ArticleId><ArticleId IdType="pubmed">37202336</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. doi: 10.1136/bmj.n1648, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Asis M. Repatriating Filipino migrant workers in the time of the pandemic. Migrat Res Series. (2020) 63</Citation></Reference><Reference><Citation>Santopaolo M, Gregorova M, Hamilton F, Arnold D, Long A, Lacey A, et al. . Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months. eLife. (2023) 12:e85009. doi: 10.7554/eLife.85009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.85009</ArticleId><ArticleId IdType="pmc">PMC10319436</ArticleId><ArticleId IdType="pubmed">37310006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth ML, Shenhuy B, Walker AS, Nafilyan V, Alwan NA, O&#x2019;Hara ME, et al. . Risk of new-onset Long COVID following reinfection with severe acute respiratory syndrome coronavirus 2: a community-based cohort study. Open forum Infect Dis. (2023) 10:ofad493. doi: 10.1093/ofid/ofad493</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad493</ArticleId><ArticleId IdType="pmc">PMC10633780</ArticleId><ArticleId IdType="pubmed">37953820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-term consequences of asymptomatic SARS-CoV-2 infection: a systematic review and Meta-analysis. Int J Environ Res Public Health. (2023) 20:1613. doi: 10.3390/ijerph20021613, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021613</ArticleId><ArticleId IdType="pmc">PMC9863678</ArticleId><ArticleId IdType="pubmed">36674367</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B, Wills M, Sithole N. Long COVID: what is known and what gaps need to be addressed. Br Med Bull. (2023) 147:6&#x2013;19. doi: 10.1093/bmb/ldad016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldad016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Loreche AM, Pepito VCF, Dayrit MM. Long COVID: a call for global action. Public Health Challenges. (2023) 2:e69. doi: 10.1002/puh2.69</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/puh2.69</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>